Suita, Japan

Hiromi Imamura


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiromi Imamura: Innovator in Fluorescently Labeled Fusion Proteins

Introduction

Hiromi Imamura is a notable inventor based in Suita, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of innovative methods for measuring adenosine triphosphate (ATP). Her work is characterized by a focus on high sensitivity and ease of handling in ATP measurement.

Latest Patents

Hiromi Imamura holds a patent for a "Fluorescently labeled fusion protein for assaying adenosine triphosphate." The objective of this invention is to provide a substance that enables the measurement of ATP with high sensitivity, regardless of protein concentration. The invention utilizes a fluorescence-labeled fusion protein that incorporates two types of fluorescent substances, which serve as potential donor and acceptor for fluorescence resonance energy transfer (FRET). This innovative approach allows for accurate measurement of ATP by contacting the fusion protein with a subject substance and measuring the resulting fluorescence spectra.

Career Highlights

Hiromi Imamura is affiliated with the New Industry Research Organization, where she continues to advance her research and development efforts. Her work has garnered attention for its potential applications in various scientific fields, including biochemistry and molecular biology.

Collaborations

Some of her notable coworkers include Hiroyuki Noji and Ryota Iino, who have collaborated with her on various research projects. Their combined expertise contributes to the innovative advancements in their field.

Conclusion

Hiromi Imamura's contributions to the development of fluorescently labeled fusion proteins represent a significant advancement in the measurement of ATP. Her innovative approach and dedication to research continue to influence the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…